Suchen
ESSA Pharma Inc
EPIXZur Watchlist hinzufügen
0.201USD
0.0000.00%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
8.93MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über ESSA Pharma Inc Unternehmen
ESSA Pharma Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is focused on developing proprietary therapies for the treatment of patients with prostate cancer. Its lead candidate, Masofaniten (formerly EPI-7386), is an oral, small molecule that inhibits the N-terminal domain of the androgen receptor (AR). Masofaniten is in development in combination with antiandrogen treatments in patients with prostate cancer who are earlier in their course of the disease. The Company is completing the clinical development of masofaniten as a monotherapy treatment for patients with metastatic castration-resistant prostate cancer (mCRPC).
ESSA Pharma Inc Informationen
BörsenkürzelEPIX
Name des UnternehmensESSA Pharma Inc
IPO-datumFeb 22, 2021
CEODr. David Ross Parkinson, M.D.
Anzahl der mitarbeiter35
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 22
Addresse999 West Broadway, Suite 720
StadtVANCOUVER
BörseNASDAQ Capital Market Consolidated
LandCanada
PostleitzahlV5Z 1K5
Telefon17783310962
Websitehttps://www.essapharma.com/
BörsenkürzelEPIX
IPO-datumFeb 22, 2021
CEODr. David Ross Parkinson, M.D.
Führungskräfte von ESSA Pharma Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jon Adkins
Mr. Jon Adkins
President, Treasurer, Secretary, Director
President, Treasurer, Secretary, Director
--
--
Mr. David Sidney Wood, CPA
Mr. David Sidney Wood, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Peter Virsik
Mr. Peter Virsik
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
-100.00%
Dr. Alessandra Cesano, M.D., Ph.D.
Dr. Alessandra Cesano, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
-100.00%
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jon Adkins
Mr. Jon Adkins
President, Treasurer, Secretary, Director
President, Treasurer, Secretary, Director
--
--
Mr. David Sidney Wood, CPA
Mr. David Sidney Wood, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Peter Virsik
Mr. Peter Virsik
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
-100.00%
Dr. Alessandra Cesano, M.D., Ph.D.
Dr. Alessandra Cesano, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
-100.00%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von ESSA Pharma Inc?
Die fünf größten Anteilseigner von ESSA Pharma Inc sind: Mr. Jon Adkins
Wie viele Institutionen halten Anteile an ESSA Pharma Inc (EPIX)?
Mit Stand vom 2025Q3 halten 79 Institutionen Anteile an ESSA Pharma Inc, mit einem Gesamtmarktwert von etwa 34.87M, was 73.70% der Gesamtanteile entspricht. Im Vergleich zum 2025Q2 ist der institutionelle Aktienbesitz um -13442442.00 gestiegen.